Headspace Gas Analysis for Pharmaceutical Packaging

The purpose of CD Formulation's headspace analysis tests for pharmaceutical packaging is to detect the residual gas content in pharmaceutical packaging and to adjust the packaging process accordingly. The residual gases inside the package should not be disregarded at the end of the packaging process. It is very difficult to control and change the gas content inside the package from the end of filling until the product is opened and used. The use of barrier packaging materials can only prevent the gas from entering/leaking out of the packaging material, but cannot eliminate the oxygen and other gases already inside the package (excluding the case of adding deaeration technology to the package). If the content of residual gas exceeds the maximum concentration required for product preservation, no matter how good the high barrier material and how well sealed packaging form can not meet the shelf-life requirements of the product. Therefore, it is necessary to detect the residual gas content in the package and adjust the packaging process accordingly. Learn more at https://www.formulationbio.com/headspace-gas-analysis-for-pharmaceutical-packaging.html.